FTH — Faeth Therapeutics, Share News
0.000.00%
Last trade - 00:00- $459.38m
- $256.60m
Sensei Biotherapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Sensei Biotherapeutics Inc Cash Runway Into Q2 Of 2026
Brief: Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data For Solnerstotug In PD-(L)1 Resistant Tumors
Sensei Biotherapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Sensei Biotherapeutics Provides Corporate Update And Highlights Key Upcoming Milestones
Sensei Biotherapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Sensei Biotherapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Sensei Biotherapeutics Says On Sept 17, Co Appointed Josiah Craver As Co’S Principal Financial Officer And Principal Accounting Officer
Sensei Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Abbvie, Lionsgate Studios, UnitedHealth Group
Brief: Sensei Biotherapeutics Reports Encouraging Clinical Data From Dose Escalation Portion Of Its Phase 1/2 Trial Of SNS-101
Sensei Biotherapeutics Inc reports results for the quarter ended in March - Earnings Summary
Sensei Biotherapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Erin Colgan Notified Sensei Biotherapeutics Of Her Resignation From All Positions With Co, Including As CFO, On March 27
Brief: Sensei Biotherapeutics Says Board Approved A Reduction In Number Of Directors On Board From Nine To Eight On Feb 6
Brief: Sensei Biotherapeutics Provides Corporate Update And Upcoming Milestones
Brief: Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
U.S. STOCKS ON THE MOVE-Paramount Global, Bumble, Booking Holdings
U.S. STOCKS ON THE MOVE-Constellation Energy, Bloomin' Brands, Air Lease